How epigallocatechin gallate can inhibit α-synuclein oligomer toxicity in vitro

Journal of Biological Chemistry

Volumn 289, Issue 31, 2014, Pages 21299-21310

  Lorenzen, Nikolai ^a,b   Nielsen, Søren B ^a,b   Yoshimura, Yuichi ^a,b   Vad, Brian S ^a,b   Andersen, Camilla Bertel ^a,b   Betzer, Cristine ^a   Kaspersen, Jørn D ^a   Christiansen, Gunna ^a   Pedersen, Jan S ^a   Jensen, Poul Henning ^a   Mulder, Frans A A ^a,b   Otzen, Daniel E ^a,b  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CELL CULTURE; CYTOTOXICITY; TOXICITY;

C-TERMINAL REGIONS; EPIGALLOCATECHIN GALLATE; MECHANISM OF ACTION; MEMBRANE AFFINITY; NEURODEGENERATIVE DISORDERS; PARKINSON DISEASE; SECONDARY STRUCTURES; SMALL MOLECULES;

OLIGOMERS;

ALPHA SYNUCLEIN; EPIGALLOCATECHIN GALLATE; OLIGOMER; BIOPOLYMER; CATECHIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL PERMEABILIZATION; CELL VIABILITY; CHANNEL GATING; CIRCULAR DICHROISM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM VESICLE; CYTOTOXICITY; DEGENERATIVE DISEASE; DIFFERENTIAL SCANNING CALORIMETRY; FIELD FLOW FRACTIONATION; IN VITRO STUDY; ISOTHERMAL TITRATION CALORIMETRY; MEMBRANE DAMAGE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; RAT; SMALL ANGLE SCATTERING; TRANSMISSION ELECTRON MICROSCOPY; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CELL MEMBRANE PERMEABILITY; METABOLISM; NUCLEAR MAGNETIC RESONANCE; TOXICITY;

ALPHA-SYNUCLEIN; BIOPOLYMERS; CALORIMETRY, DIFFERENTIAL SCANNING; CATECHIN; CELL MEMBRANE PERMEABILITY; CIRCULAR DICHROISM; IN VITRO TECHNIQUES; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, SECONDARY;

EID: 84905376066     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.554667     Document Type: Article

References (51)

1. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997) α-Synuclein in Lewy bodies. Nature 388, 839-840
2. Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., and Goedert, M. (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 95, 6469-6473 (Pubitemid 28249037)
3. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., Di Iorio, G., Golbe, L. I., and Nussbaum, R. L. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047 (Pubitemid 27443610)
4. Conway, K. A., Harper, J. D., and Lansbury, P. T. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nat. Med. 4, 1318-1320 (Pubitemid 28512115)
5. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D., Kaufman, S. A., Martin, F., Sitney, K., Denis, P., Louis, J. C., Wypych, J., Biere, A. L., and Citron, M. (1999) Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274, 9843-9846
6. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T., and Lansbury, P. T., Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291 (Pubitemid 34790672)
7. Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., Tzitzilonis, C., Soragni, A., Jessberger, S., Mira, H., Consiglio, A., Pham, E., Masliah, E., Gage, F. H., and Riek, R. (2011) In vivo demonstration that α-synuclein oligomers are toxic. Proc. Natl. Acad. Sci. U.S.A. 108, 4194-4199
8. Paleologou, K. E., Kragh, C. L., Mann, D. M., Salem, S. A., Al-Shami, R., Allsop, D., Hassan, A. H., Jensen, P. H., and El-Agnaf, O. M. (2009) Detection of elevated levels of soluble α-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132, 1093-1101
9. Tokuda, T., Qureshi, M. M., Ardah, M. T., Varghese, S., Shehab, S. A., Kasai, T., Ishigami, N., Tamaoka, A., Nakagawa, M., and El-Agnaf, O. M. (2010) Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease. Neurology 75, 1766-1772
10. Volles, M. J., Lee, S. J., Rochet, J. C., Shtilerman, M. D., Ding, T. T., Kessler, J. C., and Lansbury, P. T., Jr. (2001) Vesicle permeabilization by protofibrillar α-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40, 7812-7819 (Pubitemid 32622972)
11. Quist, A., Doudevski, I., Lin, H., Azimova, R., Ng, D., Frangione, B., Kagan, B., Ghiso, J., and Lal, R. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc. Natl. Acad. Sci. U.S.A. 102, 10427-10432 (Pubitemid 41061570)
12. Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., and Glabe, C. G. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (Pubitemid 36444329)
13. Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., and Wanker, E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558-566 (Pubitemid 351799141)
14. Hong, D. P., Fink, A. L., and Uversky, V. N. (2008) Structural characteristics of α-synuclein oligomers stabilized by the flavonoid baicalein. J. Mol. Biol. 383, 214-223
15. Conway, K. A., Rochet, J. C., Bieganski, R. M., and Lansbury, P. T., Jr. (2001) Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct. Science 294, 1346-1349 (Pubitemid 33063102)
16. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., and Wanker, E. E. (2010) EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity. Proc. Natl. Acad. Sci. U.S.A. 107, 7710-7715
17. Singh, B. N., Shankar, S., and Srivastava, R. K. (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 82, 1807-1821
18. Zhu, M., Rajamani, S., Kaylor, J., Han, S., Zhou, F., and Fink, A. L. (2004) The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils. J. Biol. Chem. 279, 26846-26857 (Pubitemid 38812518)
19. Li, J., Zhu, M., Manning-Bog, A. B., Di Monte, D. A., and Fink, A. L. (2004) Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease. FASEB J. 18, 962-964 (Pubitemid 39561492)
20. Meng, X., Munishkina, L. A., Fink, A. L., and Uversky, V. N. (2010) Effects of various flavonoids on the α-synuclein fibrillation process. Parkinsons Dis. 2010, 650794
21. Ehrnhoefer, D. E., Duennwald, M., Markovic, P., Wacker, J. L., Engemann, S., Roark, M., Legleiter, J., Marsh, J. L., Thompson, L. M., Lindquist, S., Muchowski, P. J., and Wanker, E. E. (2006) Green tea (-)-epigallocatechin- gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum. Mol. Genet. 15, 2743-2751 (Pubitemid 44400401)
22. Meng, F., Abedini, A., Plesner, A., Verchere, C. B., and Raleigh, D. P. (2010) The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry 49, 8127-8133
23. Ferreira, N., Saraiva, M. J., and Amleida, M. R. (2011) Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation. FEBS Lett. 585, 2424-2430
24. Chandrashekaran, I. R., Adda, C. G., MacRaild, C. A., Anders, R. F., and Norton, R. S. (2010) Inhibition by flavonoids of amyloid-like fibril formation by Plasmodium falciparum merozoite surface protein 2. Biochemistry 49, 5899-5908
25. Hudson, S. A., Ecroyd, H., Dehle, F. C., Musgrave, I. F., and Carver, J. A. (2009) (-)-Epigallocatechin-3-gallate (EGCG) maintains κ-casein in its pre-fibrillar state without redirecting its aggregation pathway. J. Mol. Biol. 392, 689-700
26. Roberts, B. E., Duennwald, M. L., Wang, H., Chung, C., Lopreiato, N. P., Sweeny, E. A., Knight, M. N., and Shorter, J. (2009) A synergistic small-molecule combination directly eradicates diverse prion strain structures. Nat. Chem. Biol. 5, 936-946
27. Palhano, F. L., Lee, J., Grimster, N. P., and Kelly, J. W. (2013) Toward the molecular mechanism(s) by which EGCG treatment remodels mature amyloid fibrils. J. Am. Chem. Soc. 135, 7503-7510
28. Herrera, F. E., Chesi, A., Paleologou, K. E., Schmid, A., Munoz, A., Vendruscolo, M., Gustincich, S., Lashuel, H. A., and Carloni, P. (2008) Inhibition of α-synuclein fibrillization by dopamine is mediated by interactions with five C-terminal residues and with E83 in the NAC region. PLoS One 3, e3394
29. Norris, E. H., Giasson, B. I., Hodara, R., Xu, S., Trojanowski, J. Q., Ischiropoulos, H., and Lee, V. M. (2005) Reversible inhibition of α-synuclein fibrillization by dopaminochrome-mediated conformational alterations. J. Biol. Chem. 280, 21212-21219 (Pubitemid 40805683)
30. Giehm, L., Svergun, D. I., Otzen, D. E., and Vestergaard, B. (2011) Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation. Proc. Natl. Acad. Sci. U.S.A. 108, 3246-3251
31. Zijlstra, N., Blum, C., Segers-Nolten, I. M., Claessens, M. M., and Subramaniam, V. (2012) Molecular composition of sub-stoichiometrically labeled α-synuclein oligomers determined by single-molecule photobleaching. Angew. Chem. Int. Ed. Engl. 51, 8821-8824
32. Lorenzen, N., Nielsen, S. B., Buell, A. K., Kaspersen, J. D., Arosio, P., Vad, B. S., Paslawski, W., Christiansen, G., Valnickova-Hansen, Z., Andreasen, M., Enghild, J. J., Pedersen, J. S., Dobson, C. M., Knowles, T. P., and Otzen, D. E. (2014) The role of stable α-synuclein oligomers in the molecular events underlying amyloid formation. J. Am. Chem. Soc. 136, 3859-3868
33. van Rooijen, B. D., Claessens, M. M., and Subramaniam, V. (2008) Membrane binding of oligomeric α-synuclein depends on bilayer charge and packing. FEBS Lett. 582, 3788-3792
34. Lorenzen, N., Lemminger, L., Pedersen, J. N., Nielsen, S. B., and Otzen, D. E. (2014) The N terminus of α-synuclein is essential for both monomeric and oligomeric interactions with membranes. FEBS Lett. 588, 497-502
35. van Rooijen, B. D., Claessens, M. M., and Subramaniam, V. (2009) Lipid bilayer disruption by oligomeric α-synuclein depends on bilayer charge and accessibility of the hydrophobic core. Biochim. Biophys. Acta 1788, 1271-1278
36. van Rooijen, B. D., van Leijenhorst-Groener, K. A., Claessens, M. M., and Subramaniam, V. (2009) Tryptophan fluorescence reveals structural features of α-synuclein oligomers. J. Mol. Biol. 394, 826-833
37. Stöckl, M. T., Zijlstra, N., and Subramaniam, V. (2013) α-Synuclein oligomers: an amyloid pore? Insights into mechanisms of α-synuclein oligomer-lipid interactions. Mol. Neurobiol. 47, 613-621
38. van Rooijen B. D., Claessens, M. M., Subramaniam V. (2010) Membrane permeabilization by oligomeric α-synuclein: In search of the mechanism. PLoS One 5, e14292
39. Richter-Landsberg, C., and Heinrich, M. (1996) OLN-93: a new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J. Neurosci. Res. 45, 161-173 (Pubitemid 26257317)
40. Angelova, M. I., and Dimitrov, D. S. (1986) Liposome electroformation. Faraday Discuss. Chem. Soc. 81, 303-311
41. Bagatolli, L. A., and Gratton, E. (1999) Two-photon fluorescence microscopy observation of shape changes at the phase transition in phospholipid giant unilamellar vesicles. Biophys. J. 77, 2090-2101 (Pubitemid 29463170)
42. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6, 277-293
43. Pedersen, J. S. (2004) A flux- and background-optimized version of the NanoSTAR small-angle x-ray scattering camera for solution scattering. J. Appl. Crystallogr. 37, 369-380
44. Pedersen, J. S., and Gerstenberg, M. C. (1996) Scattering form factor of block copolymer micelles. Macromolecules 29, 1363-1365
45. Guinier, A. (1939) La diffraction des rayons X aux tres petits angles; application a l'etude de phenomenes ultramicroscopiques. Ann. Phys. 12, 161-237
46. Debye, P. (1947) Molecular-weight determination by light scattering. J. Phys. Colloid. Chem. 51, 18-32
47. Mysling, S., Betzer, C., Jensen, P. H., and Jorgensen, T. J. (2013) Characterizing the dynamics of α-synuclein oligomers using hydrogen/deuterium exchange monitored by mass spectrometry. Biochemistry 52, 9097-9103
48. Paslawski, W., Mysling, S., Thomsen, K., Jørgensen, T. J. D., and Otzen, D. E. (2014) Co-existence of two different α-synuclein oligomers with different core structures determined by hydrogen/deuterium exchange mass spectrometry. Angew. Chem. Int. Ed. Engl. 10.1002/anie.201400491
49. Morar, A. S., Olteanu, A., Young, G. B., and Pielak, G. J. (2001) Solvent-induced collapse of α-synuclein and acid-denatured cytochrome c. Protein Sci. 10, 2195-2199 (Pubitemid 32988636)
50. Kjaer, L., Giehm, L., Heimburg, T., and Otzen, D. (2009) The influence of vesicle size and composition on α-synuclein structure and stability. Biophys. J. 96, 2857-2870
51. Goddard T. D., and Kneller, D. G. (2008) SPARKY, Version 3, University of California, San Francisco